Artificial Intelligence in the Pharma Industry

While the concept of artificial intelligence (AI) began gelling more than 50 years ago, its use in the pharmaceutical industry is just starting to gain significant traction. In January, the first drug designed entirely using AI entered the human clinical trials phase—five times faster than it usually takes to get a drug to this stage. But is the rest of the industry ready to deploy AI technologies? Download the whitepaper.

Saving Development Time with Single Vendor Approach
November 20, 2020 | 11am ET / 8am PT | Thermo Fisher Scientific

Watch this webinar to learn how using a single vendor will save you time and money. The presentation will focus on the Integrated Offering and how it is defined for the client, with the focus on simplicity, time savings, reduced risk, and proven experience. Register now.

Hindsight is so 2020 - Getting Ahead of CNS Trial Enrollment in a Rapidly Changing Clinical Landscape
November 18, 2020 | 1pm ET / 10am PT | Rho

The past six months have highlighted both existing and unexpected enrollment challenges, as sponsors, CROs, and sites have been pressed to evolve their recruitment strategies. Join us as Rho experts discuss their approach to adapting CNS trial enrollment to a rapidly changing clinical landscape. Register now.

Best Practices for Implementing and Maintaining Successful Standards
November 17, 2020 | 11am ET / 8am PT | 4G Clinical and Veeva

Few organizations maintain standards successfully over time. Join this webinar to develop best practices and checklists that can be applied across any size organization, regardless of standard type, to ensure efficient clinical trials. Register now.

COVID-19 Vaccine Clinical Trials in Children: Challenges on the Horizon
Elligo Health Research®

Vaccine trials against COVID-19 are leading the effort before studies begin in children. This white paper describes the challenges facing COVID-19 pediatric clinical trials from protocol to planning of pediatric sites. Download the whitepaper.

Cut Time, Not Corners: Smart Processes to Include in Your Phase 1 Clinical Development Program to Save Time & Cost Yet Add Value to Your Clinical Asset
Thursday, November 12, 2020 | 12pm ET / 9am PT | Frontage Laboratories

Phase 1 clinical program planning is complicated these days with added pressure to get maximum study data and move quickly to Phase 2 or partner the clinical asset. During this webinar, presenters will review specific study components which can be highly beneficial in terms of time and cost savings when included in a Phase 1/ First-in-Man clinical studies. Register now for an insightful overview for anyone new to Phase 1 clinical study operations and useful information for those who have not run an early clinical program in some time.

Cell and Gene Therapy - CMC Challenges and Strategies
Wednesday, November 11, 2020 | 1pm ET / 10am PT | Cardinal Health

In this webinar, experts from Cardinal Health Regulatory Sciences discuss CMC challenges and potential mitigation strategies illustrated through multiple case studies. Cell and gene therapy developers, research scientists, regulatory and legal professionals are all encouraged to attend. Register Now!

Elevate Your Digital Events Strategy

Looking for ways to engage with HCPs more effectively in your virtual events? Join this 45-minute webinar including a live Q&A, on Tuesday, November 10, and learn how to optimize customer engagement across channels. Register Now

How technologies are transforming high volume injections - essential enablers for patient outcomes
November 5, 2020 | 11 a.m. EST / 7 a.m. PST | West Pharmaceutical Services

This webinar will explore why adherence, safety and quality of life are important for patients, and how these key enablers contribute towards positive outcomes. We will also discuss existing challenges, such as drug development, regulatory, patient accessibility, and how device technologies can further improve patient outcomes. Register now.

Lifecycle Management Strategies Targeted For Patient Populations with Swallowing Disorders
November 5, 2020 | 11 a.m. EST / 8 a.m PST | Adare Pharma Solutions

This webinar will discuss life cycle management strategies for patients with swallowing disorders and the overall impact on patient perception. The webinar will include several panel speakers representing different perspectives and case study examples. Register now.

Highly Potent Strategies from Early Development to Commercialization
November 4, 2020 | 11am ET / 8am PT | Thermo Fisher Scientific

Pharmaceutical R&D is focusing on developing ever more specialized drugs, resulting in increasingly more potent APIs. Therefore, the demand for highly potency drug product manufacturing has been steadily increasing over the years and this trend is expected to continue. Is your highly potent strategy efficient and optimal to scale-up? Register now.

Characterizing Drug Substance Properties Early Can Optimize Drug Product Formulation
Thermo Fisher Scientific

Changes in the Drug Substance (DS) process as it scales up can affect the Drug Product (DP). As processes change, many properties of the DS can also change. Therefore, as DS manufacturers evaluate and optimize the synthetic route, process conditions, crystallization solvents, etc., they must understand and track these changes, and discuss them with DP formulators to anticipate challenges in formulation. Download Now. 

Position Your Pharmaceutical Lab for Success

LabVantage Pharma, the first pre-configured, pre-validated laboratory information management solution dedicated to pharmaceuticals, reduces cost and risk by deploying needed functionality without custom code. Serving regulated industries, the LIMS helps ensure regulatory and data integrity compliance. Download the whitepaper.


This paper demonstrates how an integrated compliance model leads to increases in safety, efficiencies and it can move the needle from cost center to value; by demonstrating the value of increasing data-driven and technology-infused competitiveness in the successful commercialization of a new-age biopharma product. Download Now.

Building a Flexible, Challenge Resistant and Patient Centric Clinical Supply Chain
October 27, 2020 | 11am ET / 8am PT | Catalent

In this webinar, learn the benefits of utilizing demand-led supply and direct-to-patient distribution models in the clinical supply chain, as well as how they can be used to both improve flexibility and better align with patient needs. Register now. 

Streamline Your Clinical Research Organization's Processes End to End, Featuring IQVIA and Syntactx
Recorded on October 22, 2020 | Salesforce and FinancialForce

Learn why consolidating Discovery, Pre-Clinical, Clinical, and Post Approval processes on a single platform drives efficiencies, margin improvement, and real time collaboration internally & externally. Register now!

Gene therapy viruses’ production and quality control
Recorded on Thursday, October 22, 2020 | Frontage Labs

Gene therapy has become a one-time treatment method for a complete cure by fixing genomic errors which altered protein functions of normal cells. The high titer virus packaging and purity are essential for the success of clinical gene therapy. In this presentation, we report to establish a facility to manufacture GLP grade viruses and to develop the relevant QC assays at Frontage. Our efforts will facilitate the application of this modern cutting edge technology in clinical arena. Register Now.

Patient Affordability Legislation: How This Frontier in the Pharmaceuticals Industry May Shape Your Business

This white paper outlines how one such law, Minnesota’s Alec Smith Insulin Affordability Act, has impacted the pharmaceutical industry and provides guidance about strategies businesses can employ to rapidly add support. Download Now. 

Leveraging a "Reverse Engineering Methodology" in Drug Development for On-time Delivery during COVID-19
Recorded on Wednesday, October 21, 2020 | Cambrex

Join us for a live webcast that will showcase valuable case studies and new methodologies that can help the wider CDMO industry in tackling delays in project deliveries. We will also cover our strategy to ensure the delivery of drugs to customers and patients in spite of the COVID-19 outbreak. Register now.

Pathways to Value: Biopharma's Options for Global Expansion
Recorded on October 20, 2020 | Blue Matter Consulting

US biopharma companies have options for ex-US expansion. But how can a company decide on its best pathway to value? In this webinar, leaders who’ve done it outline how they weighed their options and made the right decisions.

ClinicaLive™ - Rapid Access to Global Patient-Level Data
Evidera, a PPD business

An alternative or add-on to traditional chart review data collection methods, ClinicaLive utilizes Evidera's global network of 2.2 million HCPs to provide IRB-approved, rapid real-world evidence that can withstand the rigor of top tier journal peer review. Learn more.

Companies Need An Effective Remote Workforce Cloud Strategy To Survive
Outer Edge Technology

A sound Cloud Strategy provides the flexibility and tools businesses need to quickly adapt and operate securely in an ever-changing remote work environment. Learn how your company can cost-effectively empower its employees to be productive and secure while working remotely. Download Now

Global Genes Webinar Series
Evidera, a PPD business

Global Genes and the Child Neurology Foundation recently released a white paper outlining a set of principles for rare disease care and access that are universally relevant to all rare disease patients. Join this three-part webinar series to gain insight into the report's five core guiding principles. Register now.

Paid Marketplace
Join Catalent for our Virtual Partner Presentations at AAPS PharmSci 360

Attend our partner presentations and learn data driven strategies to accelerate your molecule development. Discover Catalent’s OptiDose™ Design Solution, a structured approach to dose form design. Don’t miss our scientific research poster on Lipid-based Formulation that will be presented virtually. Register now. 

A Guide to Regulatory Policies on Post-Marketing Requirements for Drug and Medical Device Makers
Recorded on October 15, 2020 | Elsevier

This webinar explores the latest regulatory requirements in the post-marketing setting. It provides details about some of the most recent developments in this area, including a move by the FDA in 2018 to require that companies marketing drug-device combination products report all complaints about safety to the agency. Register now!

Gene and Cell Therapy: Planning for Manufacturing Success Early

Gene and cell therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations throughout development. In this document, Aldevron provides an in-depth look at preparing for plasmid manufacturing based on our years of experience. Download now.

The Faster Path to Self-Administration: Moving from Pre-Filled Syringe to Auto-Injector
Recorded on October 15, 2020 | Catalent

In this webinar, Catalent Biologics shares how to transition your product from pre-filled syringe to auto-injector more quickly with an experienced partner who can anticipate equipment and process needs. Register now.

How to Deliver a Seamless Virtual Selling Experience
Recorded on October 14, 2020 | Salesforce

Join this webinar to learn how to more efficiently engage with customers remotely using your digital footprint, how to maximize product launches virtually, and how to proactively identify customer support needs by leveraging analytics and insights. Register now!

Digitize remote site monitoring with Box
Recorded on Tuesday, October 13, 2020 | 2pm ET / 11am PT | Box

Accelerate R&D processes across the value chain, maintain GxP compliance and reduce your overall IT footprint. Access, collaborate, and exchange non regulated and regulated content from one repository with Box. Register Now

Go from Process R&D to Clinical APIs Quickly and Effectively
Cascade Chemistry, API CDMO

Speed, Collaboration, and Expertise. That’s what Cascade Chemistry brings to API process R&D and clinical manufacturing for Phase 1&2 trials. Growing over 40 years into an API CDMO, we’ve mastered the art of strategic partnership and deliver innovative solutions to clients’ complex chemistry. Download now.

New EHR-Based RWD on Type-2 diabetes therapy IDegLira in US clinical practice

Researchers from Novo Nordisk, Medical College of Wisconsin and Veradigm have published a new study in the journal Diabetes Therapy, employing de-identified patient data sourced from a nationwide, electronic health record platform. Download this article now at no charge.

Paid Marketplace
Connect with Baxter at CPhI Festival of Pharma Virtual Event
Baxter BioPharma Solutions

Formulation challenges. Clinical supply hurdles.  Lifecycle management. Risk mitigation. Patent expiry concerns. At BioPharma Solutions, a business unit of Baxter, we know the high-stakes challenges you face in today’s complex parenteral marketplace — and how the work we do is vital to the patients you serve.

If you have an injectable molecule and are looking for sterile contract manufacturing services, we invite you to connect with us at CPhI Festival of Pharma virtual event October 5-19, 2020 using this link

Paid Marketplace
How Can Extrusion Benefit your Pharmaceutical Oral Drug Product?

As a continuous manufacturing process, extrusion was cemented in pharmaceutical manufacturing in 1980s with market launch of sustained-release Verapamil, which contains embedded crystalline active pharmaceutical ingredient (API) in polymers. Following the Verapamil launch, researchers have turned to hot melt extrusion (HME) as an effective enabling technology to manufacture amorphous solid dispersions (ASDs) for poorly soluble compounds.

Click here to learn more.

IVDR – A Game Changer for Companion Diagnostics in Europe
Recorded on: October 8, 2020 | Qiagen

The testing landscape for companion diagnostics (CDx) in Europe will change. Register now and learn how to ensure patient access to IVDR-compliant CDx in Europe. 

Mitigating Covid-19 through a hybrid decentralized clinical trials approach
October 7, 2020 | 1pm ET / 10am PT | Rho

COVID-19 has presented the industry with many risks and challenges to the management of clinical trials. For many, the mitigation of these issues has accelerated the implementation of decentralized approaches to trials. Join us as we discuss these issues, ways they can be addressed, and Rho as a case study. Register now. 

From Concept to Market: Overcoming the Challenges of Manufacturing and Clinical Trials
Recorded on Tuesday, October 6, 2020 | Alta Sciences

In this webinar, we will reveal the inner workings of the manufacturing and pharmacy department of a CRO/CDMO, so you understand the different regulatory and operational considerations faced by a clinical research pharmacy. You will learn about inherent challenges, and the appropriate mitigation measures and optimization solutions that deliver the most effective results and outcomes. What will you learn: Study planning, including quantity calculation, and how to minimize deviations, safely and successfully working with Schedule I products, packaging and labeling requirements for different countries and jurisdictions, and shipping and importation logistics during the COVID-19 era. Register Now.

Drug Product Process Development: Ensuring a Consistent, High-quality Biologic

Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and expectations for a development and manufacturing partner during the drug product process development phase. Download now.

How to Achieve Time and Cost Reductions in Clinical Trial Design and Build

Learn how to save time and reduce costs and complexity by streamlining the clinical trial process. Find out more about the various automated processes that can help to achieve these efficiencies, and reduce manual work. See how to improve the quality of metadata and increase consistency across studies. Download now.

Paid Marketplace
Engineering Commercial Manufacturing Pathways for Complex Chemistry & Biologics

Learn how BioVectra is leveraging world class process science expertise and engineering experience to facilitate rapid scale-up of small molecule and biologic drugs while reducing manufacturing CoGs.

Read about our approach here. Connect with us at the CPhI Festival of Pharma: [email protected].

High Content Screening in 3D: Faster 3D Image & Multi-Parametric Data Analysis
The PerkinElmer Signals Screening Team

Creating integrated HCS workflows in a single platform increases accuracy; reduces time and helps to identify the most appropriate hits or drug candidates. Learn more about a reliable method for creating a more efficient, faster, 3D image and multi-parametric data analysis workflow. Download Now. 

CMC Considerations for Successful Early Drug Development

A key hurdle for any drug development program is bringing the drug to clinical studies. Astute companies strategize past this milestone and plan for clinical and regulatory success. Lack of preparation for scale-up activities needed for eventual commercialization can often cause major time delays, increased costs, and a significant amount of rework. This eBook provides insights on key approaches and considerations for preparing your program for long-term success. Download now.

Paid Marketplace
Online Graduate Programs Designed for Your Career
Drexel University Online

Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career.  Learn more.

State of Life Sciences | 2020 Trends Report
LexisNexis Risk Solutions Health Care – Life Sciences

The life sciences industry is fluidly changing, with growth in the pharmaceutical sector hitting unprecedented rates. High investment rates, accelerated development of new vaccines, dominance of global pharma hub spots are amongst the few highlights in this report. Download this report to learn TOP Life Science Trends in 2020 and the highest risk pharma hubs around the globe.

Exploring the patient dynamic from different perspectives
ICON Clinical Research Ltd

The culture of clinical research is evolving from one directed by researchers to one driven by the needs of patients and those who care for them. While it seems fairly obvious that drug development is centered on the patient, the truth is that patients were not always an integral part of the process. Perhaps more importantly, patients were not involved in the conversation as to whether the drugs being developed would actually be beneficial and improve the patient’s quality of life. Download Now

Planning Successful Launches

Developing and bringing a new drug to market is a long, expensive and uncertain process. Read this article to learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. Download now.

Research Reveals New Launch Standards for First-to-launch Pharma and Biotech Companies

From 2016-2018, 27 companies – representing treatment options ranging from orphan drugs to specialty products to chronic therapies – launched products for the first time in the United States, and data is available for 25. The performance of these newcomers illuminates emerging new launch standards for pharmaceutical and biotech companies. Download the whitepaper.

Making Data Central to Your CNS and Pain Trials
Clinical Ink

A provider offering a robust set of capabilities — such as video recording for central-rater review — is more likely to be able to accommodate the needs of your trial, providing you with the necessary tools to simplify monitoring and oversight. Learn more about Clinical Ink’s CNS solution. Download now.

Technology Transfers: Reaping Rewards, Reducing Risks
Thermo Fisher Scientific

There are a number of strategic advantages companies can achieve in pharmaceutical production by transferring production between sites. They can safeguard supply by producing at more than one site, and improve distribution by moving production closer to critical markets. Download now.

Phase Appropriate Expertise and Technologies to Accelerate Product Development to Commercialization
On-Demand | Catalent

In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. The experts share collaborative best practices and explain how features of Catalent’s OneXpress™ can reduce risks, accelerate timelines, and maximize utilization of resources across a global network to drive more successful outcomes. Watch now.

Conventional vs. Unconventional Spray Drying Strategies: Development to Commercialization
Recorded on September 30, 2020 | Thermo Fisher Scientific

Leverage spray drying to combat bioavailability and processing challenges. Learn more as global industry experts provide insight from early development to commercialization. Register now.

Antibody-Drug Conjugates: Catalysts for Chemistry

Download our white paper to learn more about the growth trends, complex anatomy and intricacies of developing these armed antibodies, as well as AMRI’s approach to their discovery and development.

Paid Marketplace
Samsung Biologics Takes Innovation To The Next Level
Samsung Biologics

Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development, manufacturing, and laboratory testing services. Look for our webinars during the CPhI workshops to learn about how we adapt to the ever-changing business environment in this industry to flexibly cater to our clients' varying needs.

  • The Future of Drug Manufacturing, 11:00 – 12:00 Wed 7th Oct
  • Redefining Supply Chain Resiliency, 11:00 – 12:00 Thu 8th Oct

For more, visit our Virtual Exhibition Hall, and get in touch through [email protected]

West addresses challenges for oncology drug development & delivery
September 30, 2020 11 a.m. EST / 8 a.m. PST | West Pharmaceutical Services, Inc.

This webinar will place the oncology patient and the drug company at the heart of the conversation and will give situational awareness of the challenges both parties face, along with the proven solutions to help overcome these challenges. Register now.

The Chronic Microcap Trap: How Launch Is the Escape for True Growth

This white paper discusses how pre-commercial pharma companies that commercialize products independently can see an average market capitalization six times greater than companies who consistently license.  Learn more how these decisions impact the current and future market valuation. Download Now.

De-risk Antibody and CAR-T Safety by Identifying Off-target Specificity
Recorded on Tuesday, September 29, 2020 | Integral Molecular Inc

This webinar assembles experts with experience in biotech, pharma, and the FDA to discuss how to best identify the off-target liabilities of antibody and CAR-T therapies that are the primary cause of failure in preclinical and early clinical studies. Register Now

Paid Marketplace
Largest CRO in Japan, Providing Global End-to-End Solutions
CMIC Group

CMIC Group is the largest clinical CRO in Japan with a global footprint; providing full service solutions for drug development from preclinical testing to clinical trial management, manufacturing to sales and marketing. Read now.

Using Big Data to Take Quality Beyond Compliance
September 24, 2020 2 p.m. EST / 11 a.m. PST | MasterControl

In this webinar, learn how an advanced quality management system (QMS) that connects data across the product life cycle can provide business intelligence insights and give management a better understanding of your processes and how to improve them. Register now.

Preparing for commercialization while you’re in development
Recorded on September 24, 2020 | Model N

In this webinar, pharma industry expert, Jesse Mendelsohn, VP of Model N, shares data-driven strategies to help you establish and negotiate commercial contracts with payers and providers, build and tune your European and overseas launch strategy, and make your product available to US government health insurance programs. Register today!

New vaccines? How to go from zero to serialized in six months.
September 23, 2020 11 a.m. EST / 8 a.m. PST | Systech

Whether you’re developing a COVID-19 treatment or introducing a new drug to the market, serialization is a requirement. Learn why a configurable solution will get you to compliance faster, future-proof your deployments and reduce total cost of ownership. Register now.

Technology Transfers: Best Practices for Optimizing Success and Mitigating Risk
Recorded on September 22, 2020 | Thermo Fisher Scientific

Learn how technology transfers can optimize success and mitigate risk from product development to commercial launch. Register now!

ESMO Postview: Highlights from the virtual conference
September 22, 2020 3 p.m. EST / 12 p.m. PST | Fierce Biotech

Cancer experts and pharma execs will break down the headline-making data from ESMO, sharing their insights and analysis around the conference’s most closely watched studies. This discussion will examine how groundbreaking research unveiled over the weekend will change clinical practice and prime drugs for key new indications, and panelists will fill you in on the need-to-know takeaways from oncology’s hottest fields. Register now.

Wearable Technology for High-Frequency Cognitive and Mood Assessments in Depression
Recorded on September 17, 2020 | Cambridge Cognition

The widespread adoption of smartphones and wearables makes monitoring symptoms in real time a credible option using brief measures designed for these devices – but is this acceptable and feasible for patients? This webinar will delve into the research findings of Takeda Pharmaceuticals, Cambridge Cognition, and CTRL Group, and share lessons learned adopting new technologies in clinical trials. Register now.

USP Elastomer Chapter Revisions Will Become Official December 2020: What you Need to Know
September 17, 2020 11 a.m. EST / 8 a.m. PST | West Pharmaceutical Services, Inc.

This webinar will explain the baseline requirements for elastomeric physicochemical and functional properties.  Examples to illustrate qualification of components for intended applications will be included.  Register now.

Increasing Patient Adherence for Isolated Populations During the Pandemic: Formulation Strategies Focused on Patient Centric Solutions
Recorded on: September 16, 2020 | Adare Pharmaceuticals

This webinar will focus on the challenges isolated populations have faced during the global pandemic related to patient adherence, and the application of formulation strategies to create more patient centric solutions. Register now.

Accelerating Pharma’s Evolution Towards a Perfect Omnichannel Engagement
Recorded on September 15, 2020 | CSL Behring & Abbott

Do you want to better engage with your customers in the new normal? Do you want to know about the secret sauce to perfecting omni-channel marketing? Join the experts to review the current strategies and discuss the key enablers to driving a personalized customer experience. Register now.